Explore recent issues of Contract Pharma covering key industry trends.
Read the full digital version of our magazine online.
Behind every facility expansion, technology investment, and quality milestone in the CDMO sector is a leadership team making deliberate choices about where to focus, how to grow, and when to take calculated risks.
Stay informed! Subscribe to Contract Pharma for industry news and analysis.
Get the latest updates and breaking news from the pharmaceutical and biopharmaceutical industry.
Discover the newest partnerships and collaborations within the pharma sector.
Keep track of key executive moves and promotions in the pharma and biopharma industry.
Updates on the latest clinical trials and regulatory filings.
Stay informed with the latest financial reports and updates in the pharma industry.
A video roundup of the week’s top industry news stories.
Expert Q&A sessions addressing crucial topics in the pharmaceutical and biopharmaceutical world.
In-depth articles and features covering critical industry developments.
Access exclusive industry insights, interviews, and in-depth analysis.
Insights and analysis from industry experts on current pharma issues.
A one-on-one video interview between our editorial teams and industry leaders.
Listen to expert discussions and interviews in pharma and biopharma.
Contract Pharma Stream offers a centralized destination where users can watch expert-led sessions anytime, anywhere
A detailed look at the leading US players in the global pharmaceutical and BioPharmaceutical industry.
Browse companies involved in pharmaceutical manufacturing and services.
Comprehensive company profiles featuring overviews, key statistics, services, and contact details.
A comprehensive glossary of terms used in the pharmaceutical and biopharmaceutical industry.
Watch in-depth videos featuring industry insights and developments.
Download in-depth eBooks covering various aspects of the pharma industry.
Access detailed whitepapers offering analysis on industry topics.
View and download brochures from companies in the pharmaceutical sector.
Explore content sponsored by industry leaders, providing valuable insights.
Stay updated with the latest press releases from pharma and biopharma companies.
Explore top companies showcasing innovative pharma solutions.
Meet the leaders driving innovation and collaboration.
Engage with sessions and panels on pharma’s key trends.
Hear from experts shaping the pharmaceutical industry.
Join online webinars discussing critical industry topics and trends.
A comprehensive calendar of key industry events around the globe.
Live coverage and updates from major pharma and biopharma shows.
Find advertising opportunities to reach your target audience with Contract Pharma.
Review the editorial standards and guidelines for content published on our site.
Understand how Contract Pharma handles your personal data.
View the terms and conditions for using the Contract Pharma website.
What are you searching for?
Will move from a patchwork of legacy LIMS solutions to a foundation centered on Sapio LIMS.
By: Charlie Sternberg
Expands its drug development capabilities.
Farwell succeeds Jordan Dubow, who will continue to serve as a consultant and chair of the Clinical Advisory Board.
By: Rachel Klemovitch
McCall has served as the company’s Chief Financial Officer (CFO) since 2022.
The ODYSSEY-HCM trial did not meet its primary endpoints.
Will utilize Sapio LIMS to enhance research workflows, improve data integrity, and support scalable innovation.
By deploying Sapio’s unified informatics platform, Schrödinger is transforming its wet lab operations, integrating data, and streamlining workflows.
Unveils enhanced capabilities for chemistry, immunogenicity, GMP and molecular biology.
The study failed to demonstrate a statistically significant improvement in depression symptoms compared to placebo.
To integrate Sapio LIMS with waters_connect for Quantitation liquid chromatography mass spectrometry software.
By: Kristin Brooks
Unveils new brand identity as it sets its sights on future growth.
Mike D’Ambrosio will lead strategic initiatives to enhance customer engagement and delivery across RWE.
The chief executive of Botanical Solution Inc. (BSI) speaks about the development of QS-21 adjuvant for vaccines from Quillaja saponaria trees grown in BSI labs
By: Tim Wright
Aim to use a combination of high-throughput empirical and AI/machine learning approaches to develop novel saponin-based adjuvants.
LIMS and ELN platform for research and clinical informatics has been validated for use in labs that follow GMP, GLP and GCP guidelines.
By: Anthony Vecchione
Enter the destination URL
Or link to existing content
Enter your account email.
A verification code was sent to your email, Enter the 6-digit code sent to your mail.
Didn't get the code? Check your spam folder or resend code
Set a new password for signing in and accessing your data.
Your Password has been Updated !
